Medicament for inhibiting tumour growth
Details for Australian Patent Application No. 2004210714 (hide)
International Classifications
Event Publications
4 August 2005 PCT application entered the National Phase
PCT publication WO2004/072092 Priority application(s): WO2004/072092
21 January 2010 Application Accepted
Published as AU-B-2004210714
20 May 2010 Standard Patent Sealed
26 August 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 03 Aug 2010. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 2004272484 2-pyridone derivatives as neutrophil elastase inhibitors and their use AstraZeneca AB The nature of the amendment is as shown in the statement(s) filed 12 Aug 2010. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Melbourne VIC 3000
20 January 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 03 Aug 2010
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser